The 43rd Annual CFS: Innovative Cancer Therapy for Tomorrow is dedicated to developments in diagnostics and treatments of cancer.
Topics
- Strategies to identify and mitigate treatment-related adverse effects associated with solid and liquid tumor treatment approaches
- The risks and benefits of treatment regimens based on recent clinical trials across solid and liquid tumors
- Optimal therapy based on biomarker testing across multiple solid and liquid tumors
- Individual patient and disease characteristics in treatment decisions to optimally manage solid and liquid tumors
Who should Attend
Health care professionals involved or interested in the treatment/management of patients with cancer including:
- Hematologists
- Oncologists
- Nurse practitioners
- Nurses
- Radiotherapists
- Pharmacists
- Fellows
- Immunologists
- Researchers
- Physician assistants
- Case managers
